Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Dafiga 10 mg under fasting conditions in healthy Thai volunteers
TCTR20191008001Completed
- Sponsor
- All Research
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dapagliflozin (2 arms), sponsored by All Research. Primary endpoints: Cmax at 72 hours, AUC0-t at 72 hours and 1 more. Started Dec 2019; status: completed.
02
Drugs
dapagliflozin
Beyond the preview
Go deeper on TCTR20191008001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191008001.